欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/0314/001
药品名称Pamorelin 3,75 mg Pulver zur Herstellung einer Injektionssuspension, Retardgranulat
活性成分
    • Triptorelin embonate 6.0 mg
剂型Powder for suspension for injection
上市许可持有人IPSEN PHARMA GmbH Einsteinstr. 30 D-76275 Ettlingen
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    许可日期2002/05/21
    最近更新日期2024/12/12
    药物ATC编码
      • L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
      • L02 ENDOCRINE THERAPY
      • L02A HORMONES AND RELATED AGENTS
      • L02AE Gonadotropin releasing hormone analogues
      • L02AE04 triptorelin
    申请类型
    • TypeLevel1:Known Active Substance
    • TypeLevel2:Initial Application
    • TypeLevel3:Full Dossier Article 4.8 Di 65/65
    • TypeLevel4:Chemical Substance
    • TypeLevel5:Prescription Only
    附件文件下载
      市场状态Positive
      ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase